The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rare Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Rare Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rare Disease Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Rare Disease Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Above 1‰ segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rare Disease Drug include Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., and Pfizer, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rare Disease Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Above 1‰
0.65‰～1‰
Below 0.1‰
Market segment by Application can be divided into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
The key market players for global Rare Disease Drug market are listed below:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rare Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rare Disease Drug, with price, sales, revenue and global market share of Rare Disease Drug from 2019 to 2022.
Chapter 3, the Rare Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rare Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rare Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rare Disease Drug.
Chapter 13, 14, and 15, to describe Rare Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Rare Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rare Disease Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Rare Disease Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Above 1‰ segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rare Disease Drug include Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., and Pfizer, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rare Disease Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Above 1‰
0.65‰～1‰
Below 0.1‰
Market segment by Application can be divided into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
The key market players for global Rare Disease Drug market are listed below:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rare Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rare Disease Drug, with price, sales, revenue and global market share of Rare Disease Drug from 2019 to 2022.
Chapter 3, the Rare Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rare Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rare Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rare Disease Drug.
Chapter 13, 14, and 15, to describe Rare Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Rare Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rare Disease Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Above 1‰
1.2.3 0.65‰～1‰
1.2.4 Below 0.1‰
1.3 Market Analysis by Application
1.3.1 Overview: Global Rare Disease Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Rare Disease Drug Market Size & Forecast
1.4.1 Global Rare Disease Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rare Disease Drug Sales in Volume (2017-2028)
1.4.3 Global Rare Disease Drug Price (2017-2028)
1.5 Global Rare Disease Drug Production Capacity Analysis
1.5.1 Global Rare Disease Drug Total Production Capacity (2017-2028)
1.5.2 Global Rare Disease Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rare Disease Drug Market Drivers
1.6.2 Rare Disease Drug Market Restraints
1.6.3 Rare Disease Drug Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Rare Disease Drug Product and Services
2.1.4 Novartis AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Rare Disease Drug Product and Services
2.2.4 Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business
2.3.3 Celgene Corporation Rare Disease Drug Product and Services
2.3.4 Celgene Corporation Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
2.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business
2.5.3 Pfizer, Inc. Rare Disease Drug Product and Services
2.5.4 Pfizer, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Rare Disease Drug Product and Services
2.6.4 Sanofi S.A. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alexion Pharmaceuticals, Inc.
2.7.1 Alexion Pharmaceuticals, Inc. Details
2.7.2 Alexion Pharmaceuticals, Inc. Major Business
2.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
2.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Rare Disease Drug Product and Services
2.8.4 Eli Lilly and Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novo Nordisk A/S
2.9.1 Novo Nordisk A/S Details
2.9.2 Novo Nordisk A/S Major Business
2.9.3 Novo Nordisk A/S Rare Disease Drug Product and Services
2.9.4 Novo Nordisk A/S Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Rare Disease Drug Product and Services
2.10.4 AstraZeneca Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eisai Co., Ltd.
2.11.1 Eisai Co., Ltd. Details
2.11.2 Eisai Co., Ltd. Major Business
2.11.3 Eisai Co., Ltd. Rare Disease Drug Product and Services
2.11.4 Eisai Co., Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Daiichi Sankyo Company Limited
2.12.1 Daiichi Sankyo Company Limited Details
2.12.2 Daiichi Sankyo Company Limited Major Business
2.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
2.12.4 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bayer AG
2.13.1 Bayer AG Details
2.13.2 Bayer AG Major Business
2.13.3 Bayer AG Rare Disease Drug Product and Services
2.13.4 Bayer AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Rare Disease Drug Product and Services
2.14.4 GlaxoSmithKline Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck & Co., Inc.
2.15.1 Merck & Co., Inc. Details
2.15.2 Merck & Co., Inc. Major Business
2.15.3 Merck & Co., Inc. Rare Disease Drug Product and Services
2.15.4 Merck & Co., Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Rare Disease Drug Product and Services
2.16.4 Johnson & Johnson Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Biogen, Inc.
2.17.1 Biogen, Inc. Details
2.17.2 Biogen, Inc. Major Business
2.17.3 Biogen, Inc. Rare Disease Drug Product and Services
2.17.4 Biogen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Rare Disease Drug Product and Services
2.18.4 Takeda Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Amgen, Inc.
2.19.1 Amgen, Inc. Details
2.19.2 Amgen, Inc. Major Business
2.19.3 Amgen, Inc. Rare Disease Drug Product and Services
2.19.4 Amgen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Deciphera
2.20.1 Deciphera Details
2.20.2 Deciphera Major Business
2.20.3 Deciphera Rare Disease Drug Product and Services
2.20.4 Deciphera Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Atara Biotherapeutics
2.21.1 Atara Biotherapeutics Details
2.21.2 Atara Biotherapeutics Major Business
2.21.3 Atara Biotherapeutics Rare Disease Drug Product and Services
2.21.4 Atara Biotherapeutics Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 ProQR
2.22.1 ProQR Details
2.22.2 ProQR Major Business
2.22.3 ProQR Rare Disease Drug Product and Services
2.22.4 ProQR Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rare Disease Drug Breakdown Data by Manufacturer
3.1 Global Rare Disease Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rare Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rare Disease Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Rare Disease Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Rare Disease Drug Manufacturer Market Share in 2021
3.5 Global Rare Disease Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rare Disease Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rare Disease Drug Market Size by Region
4.1.1 Global Rare Disease Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Rare Disease Drug Revenue by Region (2017-2028)
4.2 North America Rare Disease Drug Revenue (2017-2028)
4.3 Europe Rare Disease Drug Revenue (2017-2028)
4.4 Asia-Pacific Rare Disease Drug Revenue (2017-2028)
4.5 South America Rare Disease Drug Revenue (2017-2028)
4.6 Middle East and Africa Rare Disease Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rare Disease Drug Sales in Volume by Type (2017-2028)
5.2 Global Rare Disease Drug Revenue by Type (2017-2028)
5.3 Global Rare Disease Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rare Disease Drug Sales in Volume by Application (2017-2028)
6.2 Global Rare Disease Drug Revenue by Application (2017-2028)
6.3 Global Rare Disease Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rare Disease Drug Sales by Type (2017-2028)
7.2 North America Rare Disease Drug Sales by Application (2017-2028)
7.3 North America Rare Disease Drug Market Size by Country
7.3.1 North America Rare Disease Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Rare Disease Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rare Disease Drug Sales by Type (2017-2028)
8.2 Europe Rare Disease Drug Sales by Application (2017-2028)
8.3 Europe Rare Disease Drug Market Size by Country
8.3.1 Europe Rare Disease Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Rare Disease Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rare Disease Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Rare Disease Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Rare Disease Drug Market Size by Region
9.3.1 Asia-Pacific Rare Disease Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rare Disease Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rare Disease Drug Sales by Type (2017-2028)
10.2 South America Rare Disease Drug Sales by Application (2017-2028)
10.3 South America Rare Disease Drug Market Size by Country
10.3.1 South America Rare Disease Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Rare Disease Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rare Disease Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Rare Disease Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Rare Disease Drug Market Size by Country
11.3.1 Middle East & Africa Rare Disease Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rare Disease Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rare Disease Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rare Disease Drug
12.3 Rare Disease Drug Production Process
12.4 Rare Disease Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rare Disease Drug Typical Distributors
13.3 Rare Disease Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Rare Disease Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rare Disease Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Rare Disease Drug Product and Services
Table 6. Novartis AG Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Rare Disease Drug Product and Services
Table 10. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Corporation Major Business
Table 13. Celgene Corporation Rare Disease Drug Product and Services
Table 14. Celgene Corporation Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
Table 18. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer, Inc. Major Business
Table 21. Pfizer, Inc. Rare Disease Drug Product and Services
Table 22. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A. Major Business
Table 25. Sanofi S.A. Rare Disease Drug Product and Services
Table 26. Sanofi S.A. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Alexion Pharmaceuticals, Inc. Major Business
Table 29. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
Table 30. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly and Company Major Business
Table 33. Eli Lilly and Company Rare Disease Drug Product and Services
Table 34. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 36. Novo Nordisk A/S Major Business
Table 37. Novo Nordisk A/S Rare Disease Drug Product and Services
Table 38. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Rare Disease Drug Product and Services
Table 42. AstraZeneca Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Co., Ltd. Major Business
Table 45. Eisai Co., Ltd. Rare Disease Drug Product and Services
Table 46. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Daiichi Sankyo Company Limited Major Business
Table 49. Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
Table 50. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 52. Bayer AG Major Business
Table 53. Bayer AG Rare Disease Drug Product and Services
Table 54. Bayer AG Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Rare Disease Drug Product and Services
Table 58. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Merck & Co., Inc. Major Business
Table 61. Merck & Co., Inc. Rare Disease Drug Product and Services
Table 62. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 64. Johnson & Johnson Major Business
Table 65. Johnson & Johnson Rare Disease Drug Product and Services
Table 66. Johnson & Johnson Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Biogen, Inc. Major Business
Table 69. Biogen, Inc. Rare Disease Drug Product and Services
Table 70. Biogen, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Rare Disease Drug Product and Services
Table 74. Takeda Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Amgen, Inc. Major Business
Table 77. Amgen, Inc. Rare Disease Drug Product and Services
Table 78. Amgen, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Deciphera Basic Information, Manufacturing Base and Competitors
Table 80. Deciphera Major Business
Table 81. Deciphera Rare Disease Drug Product and Services
Table 82. Deciphera Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Atara Biotherapeutics Major Business
Table 85. Atara Biotherapeutics Rare Disease Drug Product and Services
Table 86. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. ProQR Basic Information, Manufacturing Base and Competitors
Table 88. ProQR Major Business
Table 89. ProQR Rare Disease Drug Product and Services
Table 90. ProQR Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Global Rare Disease Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 92. Global Rare Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 93. Market Position of Manufacturers in Rare Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 94. Global Rare Disease Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 95. Head Office and Rare Disease Drug Production Site of Key Manufacturer
Table 96. Rare Disease Drug New Entrant and Capacity Expansion Plans
Table 97. Rare Disease Drug Mergers & Acquisitions in the Past Five Years
Table 98. Global Rare Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 99. Global Rare Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 100. Global Rare Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Global Rare Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Global Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 103. Global Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 104. Global Rare Disease Drug Revenue by Type (2017-2022) & (USD Million)
Table 105. Global Rare Disease Drug Revenue by Type (2023-2028) & (USD Million)
Table 106. Global Rare Disease Drug Price by Type (2017-2022) & (USD/Dose)
Table 107. Global Rare Disease Drug Price by Type (2023-2028) & (USD/Dose)
Table 108. Global Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 109. Global Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 110. Global Rare Disease Drug Revenue by Application (2017-2022) & (USD Million)
Table 111. Global Rare Disease Drug Revenue by Application (2023-2028) & (USD Million)
Table 112. Global Rare Disease Drug Price by Application (2017-2022) & (USD/Dose)
Table 113. Global Rare Disease Drug Price by Application (2023-2028) & (USD/Dose)
Table 114. North America Rare Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 115. North America Rare Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 116. North America Rare Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 117. North America Rare Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 118. North America Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 119. North America Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 120. North America Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 121. North America Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 122. Europe Rare Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 123. Europe Rare Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 124. Europe Rare Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 125. Europe Rare Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 126. Europe Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 127. Europe Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 128. Europe Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 129. Europe Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 130. Asia-Pacific Rare Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 131. Asia-Pacific Rare Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 132. Asia-Pacific Rare Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 133. Asia-Pacific Rare Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 134. Asia-Pacific Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 135. Asia-Pacific Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 136. Asia-Pacific Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 137. Asia-Pacific Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 138. South America Rare Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 139. South America Rare Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 140. South America Rare Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 141. South America Rare Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 142. South America Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 143. South America Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 144. South America Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 145. South America Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 146. Middle East & Africa Rare Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 147. Middle East & Africa Rare Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 148. Middle East & Africa Rare Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 149. Middle East & Africa Rare Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 150. Middle East & Africa Rare Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 151. Middle East & Africa Rare Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 152. Middle East & Africa Rare Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 153. Middle East & Africa Rare Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 154. Rare Disease Drug Raw Material
Table 155. Key Manufacturers of Rare Disease Drug Raw Materials
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Rare Disease Drug Typical Distributors
Table 159. Rare Disease Drug Typical Customers
List of Figures
Figure 1. Rare Disease Drug Picture
Figure 2. Global Rare Disease Drug Revenue Market Share by Type in 2021
Figure 3. Above 1‰
Figure 4. 0.65‰～1‰
Figure 5. Below 0.1‰
Figure 6. Global Rare Disease Drug Revenue Market Share by Application in 2021
Figure 7. Hospital Pharmacies
Figure 8. Speciality Pharmacies
Figure 9. Retail pharmacies
Figure 10. Others
Figure 11. Global Rare Disease Drug Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 12. Global Rare Disease Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Rare Disease Drug Sales (2017-2028) & (K Doses)
Figure 14. Global Rare Disease Drug Price (2017-2028) & (USD/Dose)
Figure 15. Global Rare Disease Drug Production Capacity (2017-2028) & (K Doses)
Figure 16. Global Rare Disease Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Rare Disease Drug Market Drivers
Figure 18. Rare Disease Drug Market Restraints
Figure 19. Rare Disease Drug Market Trends
Figure 20. Global Rare Disease Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Rare Disease Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Rare Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Rare Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Rare Disease Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Rare Disease Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Rare Disease Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Rare Disease Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Rare Disease Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Rare Disease Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Rare Disease Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Rare Disease Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Rare Disease Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Rare Disease Drug Price by Type (2017-2028) & (USD/Dose)
Figure 35. Global Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Rare Disease Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Rare Disease Drug Price by Application (2017-2028) & (USD/Dose)
Figure 38. North America Rare Disease Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Rare Disease Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Rare Disease Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Rare Disease Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Rare Disease Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Rare Disease Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Rare Disease Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Rare Disease Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Rare Disease Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Rare Disease Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Rare Disease Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Rare Disease Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Rare Disease Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Rare Disease Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Rare Disease Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Rare Disease Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Rare Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Rare Disease Drug in 2021
Figure 79. Manufacturing Process Analysis of Rare Disease Drug
Figure 80. Rare Disease Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
